Stratus Medical is a medical device company focused on reducing pain and suffering and improving the quality of life for chronic pain patients through innovation. Stratus Medical is headquartered in Magnolia, TX, 30 minutes North of Houston George Bush Intercontinental Airport.
Our foundational technology, the NIMBUS RF Multitined Expandable Electrode was invented by a Interventional Pain Medicine Physician who wanted a large volume RF lesion to reduce the anatomical uncertainty when treating targeted nerves to provide reproducible and sustained pain relief. NIMBUS is easy to use, requires no proprietary equipment, and helps lower overall procedure costs for hospitals and ambulatory surgery centers. NIMBUS has been validated in numerous independent clinical studies, with several prospective, Level I trials currently enrolling patients.
NIMBUS received FDA clearance in 2012, followed by CE Mark certification for both NIMBUS and the Vesta system in 2021. Today, NIMBUS is available in six countries and is rapidly expanding. Stratus Medical will continue to innovate and deliver new products to market, including an RF Generator (currently under development and not FDA cleared).
To reduce pain and suffering and improve quality of life for chronic pain patients.
We are innovating and educating to improve the quality of life for patients with chronic pain.
We will treat every physician, clinician, hospital and stakeholder the way we would want to be treated.
We commit to the highest ethical and quality standards for our products that are used to treat patients.
Content
qContent
Content
Background:
Radiofrequency neurotomy (RFN) can be an effective treatment for patients with chronic neck pain and cervicogenic headaches resistant to conservative care. However, the degree and duration of pain relief after RFN is dependent upon the thoroughness of target nerve coagulation.
Case Report:
This is a case of a 37-year-old patient with debilitating neck pain and headaches following a motor vehicle accident. Successful local anesthetic block of the third occipital nerve (TON) confirmed pain of C2-C3 facet joint origin. An initial RFN treatment of the TON, using standard 18G electrodes in bipolar mode, resulted in complete symptom amelioration for 8 months. Repeat RFN, using the same electrode configuration, was unsuccessful in alleviating the severe neck pain and headaches, and produced no demonstrable sensory loss in the distribution of the TON. RFN was then performed using the NIMBUS® electrosurgical RF multitined expandable electrode, which provides a larger zone of coagulation in volume than standard RFN electrodes even when used in bipolar configuration.
Conclusion:
The NIMBUS procedure resulted in successful coagulation of the TON with sensory loss in the TON distribution and reinstatement of palliative relief.
